Literature DB >> 3651890

Immune response in skunks to a vaccinia virus recombinant expressing the rabies virus glycoprotein.

N D Tolson1, K M Charlton, R B Stewart, J B Campbell, T J Wiktor.   

Abstract

Striped skunks (Mephitis mephitis) were vaccinated with a vaccinia virus recombinant expressing the rabies virus glycoprotein. Virus neutralizing antibodies to rabies virus were present at 14 days postvaccination by the following routes: scarification (6/6), intramuscular (4/4) and intestinal (5/8). Six out of seven skunks that ate vaccine filled baits had virus neutralizing antibodies at 28 days. When challenged intramuscularly with street virus, the survival rates were 5/7 for the bait-fed group, 4/8 for the intestinal group, 3/4 for the intramuscular group, 5/6 for the animals that were scarified, and 0/8 for controls. This is the first report of a high rate of immunization of skunks with a rabies vaccine administered orally.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3651890      PMCID: PMC1255338     

Source DB:  PubMed          Journal:  Can J Vet Res        ISSN: 0830-9000            Impact factor:   1.310


  17 in total

1.  Determination of the site of oral rabies vaccination.

Authors:  G M Baer; J R Broderson; P A Yager
Journal:  Am J Epidemiol       Date:  1975-02       Impact factor: 4.897

2.  A microtest for the quantitation of rabies virus neutralizing antibodies.

Authors:  E Zalan; C Wilson; D Pukitis
Journal:  J Biol Stand       Date:  1979-07

3.  Further studies of sylvatic rabies in the fox (Vulpes vulpes). Vaccination by the oral route.

Authors:  J G Black; K F Lawson
Journal:  Can Vet J       Date:  1973-09       Impact factor: 1.008

4.  Oral immunization of foxes against rabies. Laboratory and field studies.

Authors:  F Steck; A Wandeler; P Bichsel; S Capt; U Häfliger; L Schneider
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1982       Impact factor: 2.268

5.  Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen.

Authors:  G L Smith; M Mackett; B Moss
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

6.  Laboratory techniques in rabies: the fluorescent antibody test.

Authors:  D J Dean; M K Abelseth
Journal:  Monogr Ser World Health Organ       Date:  1973

7.  Immunization of foxes Vulpes vulpes by the oral and intramuscular routes with inactivated rabies vaccines.

Authors:  K F Lawson; D H Johnston; J M Patterson; J G Black; A J Rhodes; E Zalan
Journal:  Can J Comp Med       Date:  1982-10

8.  Experimental rabies in skunks: immunofluorescence light and electron microscopic studies.

Authors:  K M Charlton; G A Casey
Journal:  Lab Invest       Date:  1979-07       Impact factor: 5.662

9.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

10.  Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus.

Authors:  D Panicali; E Paoletti
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

View more
  20 in total

1.  Studies on the stability of a human adenovirus-rabies recombinant vaccine.

Authors:  K K Kalicharran; V S Springthorpe; S A Sattar
Journal:  Can J Vet Res       Date:  1992-01       Impact factor: 1.310

2.  Immunization of foxes against rabies with a vaccinia recombinant virus expressing the rabies glycoprotein.

Authors:  N D Tolson; K M Charlton; G A Casey; M K Knowles; C E Rupprecht; K F Lawson; J B Campbell
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

3.  Vaccinia recombinant virus expressing the rabies virus glycoprotein: safety and efficacy trials in Canadian wildlife.

Authors:  M Artois; K M Charlton; N D Tolson; G A Casey; M K Knowles; J B Campbell
Journal:  Can J Vet Res       Date:  1990-10       Impact factor: 1.310

4.  Oral rabies vaccination of skunks and foxes with a recombinant human adenovirus vaccine.

Authors:  K M Charlton; M Artois; L Prevec; J B Campbell; G A Casey; A I Wandeler; J Armstrong
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

5.  Immunogenicity and relative attenuation of different vaccinia-rabies virus recombinants.

Authors:  J H Zhu; J Wang; B Cai; W Zhao; Y Zhu; R Chao; L Chen; H Xue; B L Ying; C P Li; Q L Hu; J Sha; J J Esposito
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

6.  Sickness and recovery of dogs challenged with a street rabies virus after vaccination with a vaccinia virus recombinant expressing rabies virus N protein.

Authors:  M Fekadu; J W Sumner; J H Shaddock; D W Sanderlin; G M Baer
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

7.  Overexpression of cytochrome C by a recombinant rabies virus attenuates pathogenicity and enhances antiviral immunity.

Authors:  R Pulmanausahakul; M Faber; K Morimoto; S Spitsin; E Weihe; D C Hooper; M J Schnell; B Dietzschold
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Oral vaccination of raccoons (Procyon lotor) with genetically modified rabies virus vaccines.

Authors:  Jesse D Blanton; Joshua Self; Michael Niezgoda; Marie-Luise Faber; Bernhard Dietzschold; Charles Rupprecht
Journal:  Vaccine       Date:  2007-08-22       Impact factor: 3.641

9.  The live vector approach-viruses.

Authors:  M Mackett
Journal:  World J Microbiol Biotechnol       Date:  1991-03       Impact factor: 3.312

10.  Studies of ERA/BHK-21 rabies vaccine in skunks and mice.

Authors:  N D Tolson; K M Charlton; K F Lawson; J B Campbell; R B Stewart
Journal:  Can J Vet Res       Date:  1988-01       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.